Diffusion kurtosis imaging of gliomas grades II and III - a study of perilesional tumor infiltration, tumor grades and subtypes at clinical presentation
By:
References
- Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 2013; Suppl 2: 1-56. 10.1093/neuonc/not151
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131: 803-20. 10.1007/s00401-016-1545-1
- Fan GG, Deng QL, Wu ZH, Guo QY. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 2006; 79: 652-8. 10.1259/bjr/25349497
- Schafer ML, Maurer MH, Synowitz M, Wustefeld J, Marnitz T, Streitparth F, et al. Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensities. Eur Radiol 2013; 23: 2846-53. 10.1007/s00330-013-2886-y
- Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-98.
- Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 2004; 108: 49-56. 10.1007/s00401-004-0861-z
- Gupta M, Djalilvand A, Brat DJ. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma. Am J Clin Pathol 2005; 124: 755-68. 10.1309/6JNX-4PA6-0TQ5-U5VG
- Ius T, Angelini E, Thiebaut de Schotten M, Mandonnet E, Duffau H. Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a “minimal common brain”. Neuroimage 2011; 56: 992-1000. 10.1016/j.neuroimage.2011.03.022
- Smits A, Zetterling M, Lundin M, Melin B, Fahlstrom M, Grabowska A, et al. Neurological impairment linked with cortico-subcortical infiltration of diffuse low-grade gliomas at initial diagnosis supports early brain plasticity. Front Neurol 2015; 6: 137. 10.3389/fneur.2015.00137
- Unkelbach J, Menze BH, Konukoglu E, Dittmann F, Ayache N, Shih HA. Radiotherapy planning for glioblastoma based on a tumor growth model: implications for spatial dose redistribution. Phys Med Biol 2014; 59: 771-89. 10.1088/0031-9155/59/3/771
- Mabray MC, Glastonbury CM, Mamlouk MD, Punch GE, Solomon DA, Cha S. Direct cranial nerve involvement by gliomas: case series and review of the literature. AJNR Am J Neuroradiol 2015; 36: 1349-54. 10.3174/ ajnr.A4287
- Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62: 450-9.
- Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 2006; 129: 1884-91. 10.1093/ brain/awl108
- Zetterling M, Roodakker KR, Berntsson SG, Edqvist PH, Latini F, Landtblom AM, et al. Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data. J Neurosurg 2016; 125: 1155-66. 10.3171/2015.10. JNS15583
- Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C, et al. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 2010; 74: 1724-31. 10.1212/WNL.0b013e3181e04264
- Price SJ, Jena R, Burnet NG, Hutchinson PJ, Dean AF, Pena A, et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR Am J Neuroradiol 2006; 27: 1969-74.
- Raab P, Hattingen E, Franz K, Zanella FE, Lanfermann H. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. Radiology 2010; 254: 876-81. 10.1148/radiol.09090819
- Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-67. 10.1016/S0006-3495(94)80775-1
- Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005; 53: 1432-40. 10.1002/mrm.20508
- Cheung MM, Hui ES, Chan KC, Helpern JA, Qi L, Wu EX. Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study. Neuroimage 2009; 45: 386-92. 10.1016/j.neuroimage.2008.12.018
- Szczepankiewicz F, van Westen D, Englund E, Westin CF, Stahlberg F, Latt J, et al. The link between diffusion MRI and tumor heterogeneity: Mapping cell eccentricity and density by diffusional variance decomposition (DIVIDE). Neuroimage 2016; 142: 522-3. 10.1016/j.neuroimage.2016.07.038
- Van Cauter S, Veraart J, Sijbers J, Peeters RR, Himmelreich U, De Keyzer F, et al. Gliomas: diffusion kurtosis MR imaging in grading. Radiology 2012; 263: 492-501. 10.1148/radiol.12110927
- Van Cauter S, De Keyzer F, Sima DM, Sava AC, D’Arco F, Veraart J, et al. Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas. Neuro Oncol 2014; 16: 1010-21. 10.1093/neuonc/not304
- Jiang R, Jiang J, Zhao L, Zhang J, Zhang S, Yao Y, et al. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation. Oncotarget 2015; 6: 42380-93. 10.18632/oncotarget.5675
- Tietze A, Hansen MB, Ostergaard L, Jespersen SN, Sangill R, Lund TE, et al. Mean diffusional kurtosis in patients with glioma: initial results with a fast imaging method in a clinical setting. AJNR Am J Neuroradiol 2015; 36: 1472-8. 10.3174/ajnr. A4311
- Arevalo-Perez J, Peck KK, Young RJ, Holodny AI, Karimi S, Lyo JK. Dynamic Contrast-enhanced perfusion mri and diffusion-weighted imaging in grading of gliomas. J Neuroimaging 2015; 25: 792-8. 10.1111/jon.12239
- Falk A, Fahlstrom M, Rostrup E, Berntsson S, Zetterling M, Morell A, et al. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiol 2014; 56: 1031-8. 10.1007/s00234-014-1426-z
- Emblem KE, Due-Tonnessen P, Hald JK, Bjornerud A, Pinho MC, Scheie D, et al. Machine learning in preoperative glioma MRI: survival associations by perfusion-based support vector machine outperforms traditional MRI. J Magn Reson Imaging 2014; 40: 47-54. 10.1002/jmri.24390
- Poot DH, den Dekker AJ, Achten E, Verhoye M, Sijbers J. Optimal experimental design for diffusion kurtosis imaging. IEEE Trans Med Imaging 2010; 29: 819-29. 10.1109/TMI.2009.2037915
- Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 2010; 29: 196-205. 10.1109/TMI.2009.2035616
- Lätt J NM, Brockstedt S, Wirestam R, Ståhlberg F. Bias free estimates of the diffusional kurtosis in two minutes: Avoid solving the kurtosis tensor. ISMRM: International society for magnetic resonance in medicine; 2010.
- Hansen B, Lund TE, Sangill R, Jespersen SN. Experimentally and computationally fast method for estimation of a mean kurtosis. Magn Reson Med 2013; 69: 1754-60. 10.1002/mrm.24743
- Gerin C, Pallud J, Deroulers C, Varlet P, Oppenheim C, Roux FX, et al. Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas. Neuro Oncol 2013; 15: 1379-88. 10.1093/neuonc/ not072
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109. 10.1007/s00401-007-0243-4
- Wang S, Zhou J. Diffusion tensor magnetic resonance imaging of rat glioma models: a correlation study of MR imaging and histology. J Comput Assist Tomogr 2012; 36: 739-44. 10.1097/RCT.0b013e3182685436
- Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon TD, Silva A, Bearden CE. Alterations in white matter microstructure in neurofibromatosis-1. PloS One 2012; 7: e47854. 10.1371/journal.pone.0047854
- Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 2012; 308: 1881-8. 10.1001/jama.2012.12807
- Yordanova YN, Moritz-Gasser S, Duffau H. Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection. Clinical article. J Neurosurg 2011; 115: 232-9. 10.3171/2011.3.JNS101333
- Murakami R, Hirai T, Sugahara T, Fukuoka H, Toya R, Nishimura S, et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 2009; 251: 838-45. 10.1148/radiol.2513080899
- Kinjo S, Hirato J, Nakazato Y. Low grade diffuse gliomas: shared cellular composition and morphometric differences. Neuropathology 2008; 28: 455-65. 10.1111/j.1440-1789.2008.00897.x
- Tozer DJ, Jager HR, Danchaivijitr N, Benton CE, Tofts PS, Rees JH, et al. Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed 2007; 20: 49-57. 10.1002/nbm.1091
- Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, et al. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol 2009; 2: 271-80.
- Khayal IS, McKnight TR, McGue C, Vandenberg S, Lamborn KR, Chang SM, et al. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed 2009; 22: 449-55. 10.1002/ nbm.1357
- Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 2002; 57: 219-25. 10.1053/crad.2001.0741
- Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, et al. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment? Neuro Oncol 2010; 12: 490-9. 10.1093/neuonc/nop071
Language: English
Page range: 121 - 129
Submitted on: Aug 15, 2016
Accepted on: Jan 8, 2017
Published on: Feb 15, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2017 Anna F. Delgado, Markus Fahlström, Markus Nilsson, Shala G. Berntsson, Maria Zetterling, Sylwia Libard, Irina Alafuzoff, Danielle van Westen, Jimmy Lätt, Anja Smits, Elna-Marie Larsson, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.